Bicycle Therapeutics (BCYC) Prepaid Assets (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Prepaid Assets came in at $17.8 million in Q2 2026, down 19.46% YoY from $22.1 million in Q2 2025, and down 5.22% on a QoQ basis from $18.7 million in Q1 2026.
Analysis
Bicycle Therapeutics (BCYC) Prepaid Assets (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 9 years of Prepaid Assets data on file, last reported at $17.8 million in Q2 2026.
- Quarterly Prepaid Assets fell 19.46% year-over-year to $17.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $17.8 million (down 19.46% YoY) and the FY2025 annual result came in at $19.2 million, up 42.8% from the prior year.
- Prepaid Assets fell to $17.8 million in Q2 2026, from $18.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $23.2 million in Q3 2025 to a low of $8.4 million in Q3 2022.
- A 5-year average of $15.0 million and a median of $15.2 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 101.7% — and 2026, when it fell 19.46%.
- Tracing BCYC's Prepaid Assets over 5 years: stood at $9.0 million in 2022, then grew by 26.42% to $11.4 million in 2023, then gained by 17.76% to $13.4 million in 2024, then soared by 42.8% to $19.2 million in 2025, then slipped by 7.38% to $17.8 million in 2026.
- The last three Prepaid Assets figures came in at $17.8 million (Q2 2026), $18.7 million (Q1 2026), and $19.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bicycle Therapeutics | 299.81 Mn | 299.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.77 Mn |
| Mar 31, 2026 | 18.74 Mn |
| Dec 31, 2025 | 19.18 Mn |
| Sep 30, 2025 | 23.23 Mn |
| Jun 30, 2025 | 22.06 Mn |
| Mar 31, 2025 | 16.74 Mn |
| Dec 31, 2024 | 13.43 Mn |
| Sep 30, 2024 | 17.35 Mn |
| Jun 30, 2024 | 20.22 Mn |
| Mar 31, 2024 | 19.90 Mn |
| Dec 31, 2023 | 11.41 Mn |
| Sep 30, 2023 | 13.67 Mn |
| Jun 30, 2023 | 10.02 Mn |
| Mar 31, 2023 | 10.93 Mn |
| Dec 31, 2022 | 9.02 Mn |
| Sep 30, 2022 | 8.45 Mn |
| Jun 30, 2022 | 9.45 Mn |
| Mar 31, 2022 | 9.07 Mn |
| Dec 31, 2021 | 7.97 Mn |
| Sep 30, 2021 | 5.64 Mn |